A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis
Clinical trial NCT05344365 · WITHDRAWN
Trial details
- NCT number
- NCT05344365
- Sponsor
- Vanda Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.